Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma

被引：0
|
作者：
Tong, Huan [1 ]
Li, Xiao [1 ]
Wei, Bo [1 ]
Tang, Chengwei [1 ]
机构：
[1] Sichuan Univ, Dept Gastroenterol, West China Hosp, Chengdu 610041, Peoples R China
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2015年 / 39卷 / 05期
关键词：
TRANSCATHETER ARTERIAL EMBOLIZATION; ANIMAL-MODEL; ANGIOGENESIS; ALLOGRAFTS; OCTREOTIDE;
D O I：
10.1016/j.clinre.2015.01.008
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E63 / E64
页数：2
相关论文
共 50 条
  • [41] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study
    Zhang, Jin-Xing
    Chen, Yu-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (09) : 794 - 803
  • [42] Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma
    White, Jared A.
    Redden, David T.
    Bryant, Mary Kate
    Dorn, David
    Saddekni, Souheil
    Aal, Ahmed Kamel Abdel
    Zarzour, Jessica
    Bolus, David
    Smith, J. Kevin
    Gray, Stephen
    Eckhoff, Devin E.
    DuBay, Derek A.
    [J]. HPB, 2014, 16 (12) : 1095 - 1101
  • [43] TRANSARTERIAL CHEMOEMBOLIZATION TO THE TREATMENT OF HEPATOCELLULAR CARCINOMA - PREPARATION PROCEDURES
    Ferreira, D.
    Pires, T.
    Machado, N.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E107 - E107
  • [44] Effectiveness of transarterial chemoembolization combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma
    Cao, Fei
    Yang, Yi
    Si, Tongguo
    Luo, Jun
    Zeng, Hui
    Zhang, Zhewei
    Chen, Yi
    Zheng, Jiaping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [45] Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
    Geschwind, Jean-Francois H.
    Chapiro, Julius
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 585 - 587
  • [46] Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis
    Chen, Anxin
    Li, Shijie
    Yao, Zhiyuan
    Hu, Jiahao
    Cao, Jiasheng
    Topatana, Win
    Juengpanich, Sarun
    Yu, Hong
    Shen, Jiliang
    Chen, Mingyu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 302 - 310
  • [47] Outcomes of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: A tertiary center experience
    Tahir, Misbah
    Mustafa, Khalid
    Ali, Muhammad
    Khalid, Danial
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (06) : 1196 - 1200
  • [48] Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
    Fateen, Waleed
    Khan, Farooq
    O'Neill, Richard J.
    James, Martin W.
    Ryder, Stephen D.
    Aithal, Guruprasad P.
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2017, 4 : 123 - 130
  • [49] Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
    Takayasu, Kenichi
    Arii, Shigeki
    Ikai, Iwao
    Omata, Masao
    Okita, Kiwamu
    Ichida, Takafumi
    Matsuyama, Yutaka
    Nakanuma, Yasuni
    Kojiro, Masamichi
    Makuuchi, Masatoshi
    Yamaoka, Yoshio
    [J]. GASTROENTEROLOGY, 2006, 131 (02) : 461 - 469
  • [50] Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinoma
    Fang, Zhiyuan
    Yang, Huayu
    Mao, Yilei
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (09)
12345